Lexaria to Begin New Human Clinical Study in GLP-1

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/30/2026

1. WDAY
2. ESTC
3. MRVL
4. AFRM
5. RBRK
6. S
7. GAP
8. DG
9. ULTA
10. NVDA

Go back to Lexaria to Begin New Human Clinical Study in GLP-1
(NASDAQ: LEXX) Delayed: 10.35 -1.33 (11.39%)
Previous Close $11.68    52 Week High $ 
Open $11.42    52 Week Low $ 
Day High $12.48    P/E N/A 
Day Low $10.35    EPS $ 
Volume 61,908